about
Allogeneic tumor cell vaccines: the promise and limitations in clinical trialsCancer CARtography: charting out a new approach to cancer immunotherapy.Protein transfer-mediated surface engineering to adjuvantate virus-like nanoparticles for enhanced anti-viral immune responsesInfluenza virus-like particles engineered by protein transfer with tumor-associated antigens induces protective antitumor immunity.Plasma membrane vesicles decorated with glycolipid-anchored antigens and adjuvants via protein transfer as an antigen delivery platform for inhibition of tumor growthExpression of membrane anchored cytokines and B7-1 alters tumor microenvironment and induces protective antitumor immunity in a murine breast cancer model.Effects of anchor structure and glycosylation of Fcγ receptor III on ligand binding affinityImmunotherapeutic strategies for cancer treatment: a novel protein transfer approach for cancer vaccine development.Taming dendritic cells with TIM-3: another immunosuppressive strategy used by tumors.Tumor membrane-based vaccine immunotherapy in combination with anti-CTLA-4 antibody confers protection against immune checkpoint resistant murine triple-negative breast cancer
P50
Q26852333-963081C7-AD04-4EF1-96B0-D0A5786E6749Q34139468-049F9325-C88D-4D74-8558-945B7BE73FCCQ35883016-A4C7E7FF-9521-49CD-A36F-91D05EBEE1C3Q36207818-37F3B286-9BE4-4806-BD47-C55B7929C95CQ36322686-3FE00990-3E34-4CFE-AC51-9BB47241E172Q36940633-6D0F5434-3A7F-423B-982E-AD08A6ADC1EEQ37573235-E16AF5E3-5444-43C2-A4ED-6930ED3E0949Q38051534-29155387-F041-471E-B657-F7A5955B5523Q39601470-6BF979BC-A0D1-4D2E-8D27-5F9AC5FE0C32Q96341418-9CFA8FFB-BB16-454E-8ECE-510E4ED1D7A7
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Jaina M Patel
@en
Jaina M Patel
@nl
type
label
Jaina M Patel
@en
Jaina M Patel
@nl
prefLabel
Jaina M Patel
@en
Jaina M Patel
@nl
P31
P496
0000-0002-5772-4048